{"schema_version":"secwatch.filing_event.v1","accession":"0001854270-24-000094","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.949434+00:00","generated_at":"2026-05-31T20:16:43.822295+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Senti Biosciences effectuates 1-for-10 reverse stock split effective July 17, 2024","bullets":["Reverse stock split at 1-for-10 ratio approved by Board on July 10, 2024.","Effective 5:00 p.m. ET on July 17, 2024; trading on split-adjusted basis begins July 18 under symbol SNTI.","No fractional shares issued; cash payment in lieu at July 17 closing price.","Authorized shares and par value remain unchanged; new CUSIP is 81726A209.","Reverse split intended to maintain Nasdaq listing compliance; proportional adjustments to equity awards."],"urls":{"canonical":"https://secwatch.observer/filing/0001854270-24-000094","json":"https://secwatch.observer/filing/0001854270-24-000094.json","markdown":"https://secwatch.observer/filing/0001854270-24-000094.md","text":"https://secwatch.observer/filing/0001854270-24-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000094/0001854270-24-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000094/snti-20240717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:16:43.822295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}